trending Market Intelligence /marketintelligence/en/news-insights/trending/82vnR761gUo2jXAhmgry5g2 content esgSubNav
In This List

Bellicum Pharmaceuticals closes $69M stock offering

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Bellicum Pharmaceuticals closes $69M stock offering

Bellicum Pharmaceuticals Inc. closed its underwritten public offering of 5,750,000 common shares priced at $12 per share.

The amount includes 750,000 shares that were issued as part of an overallotment option fully exercised by underwriters.

All in all, the company raised $69 million with Citigroup and Jefferies acting as the lead book-running managers for the offering. Guggenheim Securities, Ladenburg Thalmann, Raymond James and SunTrust Robinson Humphrey acted as co-managers.